Skip to main content
. Author manuscript; available in PMC: 2015 Jun 14.
Published in final edited form as: Nanotechnol Rev. 2013 Aug 9;3(2):111–122. doi: 10.1515/ntrev-2013-0013

Figure 2.

Figure 2

Comparison of short- and long-term effects of treatment with conventional agents (top panels) and NPs that use both active and passive targeting of malignant cells (bottom panels). Conventional approaches are equally effective in the short term; however, micro-metastases remain and repopulate the tumor in the long term. Targeted NPs destroy micrometastases resulting in long-term therapeutic benefit.